asa guidelines for glp-1 drugs Anesthetic Considerations Patients Taking Glucagon-Like Peptide-1 Agonists Integrating ASA Guidelines for GLP-1RA

Mitchell KG, Nelson DB, Corsini EM, Correa AM, Erasmus JJ, Hofstetter WL, Mehran RJ, Roth JA, Swisher SG , Sepesi B, Walsh GL, Vaporciyan AA, Rice DC, Nguyen QN, Antonoff MB

Clinical consensus suggests a two-pronged strategy to preserve lean muscle mass while maximizing fat loss

doi: 10.1016/j.intimp.2022.109607 58 ChengHPFengDDLiXHGaoLHQiuYJLiangXYet al

Creative Commons license and disclaimer available from: 32 Both GIP and GLP-1 have been reported to exert direct effects on the cardiovascular system in addition to pancreatic beta cells

Additionally, it can mimic insulins effects, influencing glucose metabolism and energy utilization